CURX

Curanex Pharmaceuticals
$0.18
−$0.01 (−2.66%)Jul 27, 2026
1.1PoorMoatMint rating

MoatMint rates Curanex Pharmaceuticals (CURX) 1.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.4 out of 10.

Key metrics

The numbers that frame CURX today
Market cap
$5.19M
P/E (TTM)
-0.7
EV / FCF
-0.1
ROIC
-137.8%
Div yield
0%
Debt / equity
0.0

CURX stock rating

How CURX scores on quality, value, growth, momentum and financial health
1.1out of 10
Low overallNeutral business, expensive priceTop 89% of ~5,000 US stocks
QualityPoor0.4/10
GrowthNeutral5.8/10
MomentumNo scoren/a/10
ValuePoor0.1/10
Financial HealthPoor1.2/10

Growth

Revenue and earnings trend for CURX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CURX
Is Curanex Pharmaceuticals a good buy?
No. Curanex Pharmaceuticals has poor quality. Growth looks mixed. The support signal is useful, but not decisive. We think Curanex Pharmaceuticals is selling at a very high price.
What is the market capitalization of CURX?
Curanex Pharmaceuticals's market capitalization is $5.19M.
What is the P/E ratio for CURX stock?
Curanex Pharmaceuticals's current P/E ratio is -0.7.
Does CURX stock pay dividends?
Curanex Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CURX?
Curanex Pharmaceuticals's Debt / Equity ratio is 0.04.